Therapeutic Asset Ratings
3,171 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Autologous Baffr-Targeting Car T Cells
Follicular Lymphoma
Mayo Clinic
P1
CC
(43)
Autologous Baffr-Targeting Car T Cells
Mantle Cell Lymphoma
Mayo Clinic
P1
CC
(43)
Autologous Baffr-Targeting Car T Cells
Marginal Zone Lymphoma
Mayo Clinic
P1
CC
(43)
Autologous Baffr-Targeting Car T Cells
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Mayo Clinic
P1
CC
(43)
Autologous Car19 T Lymphocytes
Non-Hodgkin Lymphoma
Institute of Hematology and Blood Transfusion, Czech Republic
P1
CC
(43)
Autologous Car19 T Lymphocytes
B-Cell Acute Lymphoblastic Leukemia
Institute of Hematology and Blood Transfusion, Czech Republic
P1
CC
(43)
Autologous Car.Cd30 Ebv Specific-Ctls
Hodgkins Lymphoma
Baylor College of Medicine
P1
CC
(43)
Autologous Car-T Cell Therapy Expressing The Baff-Ligand.
Plasma Cell Myeloma
Luminary Therapeutics
P1
CC
(43)
Autologous Ccr4 Car T Cells
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Autologous Ccr4 Car T Cells
Enteropathy-Associated T-Cell Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Autologous Ccr4 Car T Cells
Hepatosplenic T-Cell Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Autologous Ccr4 Car T Cells
Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Autologous Ccr4 Car T Cells
Neoplasm Of Mature T-Cells Or NK-Cells
National Cancer Institute (NCI)
P1
CC
(43)
Autologous Ccr4 Car T Cells
Subcutaneous Panniculitis-Like T-Cell Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Autologous Cd123Car-Cd28-Cd3Zeta-Egfrt-Expressing T Lymphocytes
Acute Biphenotypic Leukemia
City of Hope Medical Center
P1
CC
(43)
Autologous Cd123Car-Cd28-Cd3Zeta-Egfrt-Expressing T Lymphocytes
Adult Acute Lymphoblastic Leukemia
City of Hope Medical Center
P1
CC
(43)
Autologous Cd123Car-Cd28-Cd3Zeta-Egfrt-Expressing T Lymphocytes
Acute Myeloid Leukemia
City of Hope Medical Center
P1
CC
(43)
Autologous Cd123Car-Cd28-Cd3Zeta-Egfrt-Expressing T Lymphocytes
CD4+/CD56+ Hematodermic Neoplasm
City of Hope Medical Center
P1
CC
(43)
Autologous Cd19-Bcma Dual-Target Car T-Cell Therapy
Autoimmune Hemolytic Anemia
Beijing Boren Hospital
P1
CC
(43)
Autologous Cd19-Bcma Dual-Target Car T-Cell Therapy
Idiopathic Inflammatory Myopathy
Beijing Boren Hospital
P1
CC
(43)
Autologous Cd19-Bcma Dual-Target Car T-Cell Therapy
Multiple Sclerosis
Beijing Boren Hospital
P1
CC
(43)
Autologous Cd19-Bcma Dual-Target Car T-Cell Therapy
Sjogren Syndrome
Beijing Boren Hospital
P1
CC
(43)
Autologous Cd19-Bcma Dual-Target Car T-Cell Therapy
Systemic Lupus Erythematosus
Beijing Boren Hospital
P1
CC
(43)
Autologous Cd19-Bcma Dual-Target Car T-Cell Therapy
Systemic Sclerosis
Beijing Boren Hospital
P1
CC
(43)
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tcm-Enriched T Cells
Grade III Lymphomatoid Granulomatosis
City of Hope Medical Center
P1
CC
(43)
Showing 1076 to 1100 of 3,171 assets
Previous
Page 44 of 127
Next
